Respiratory Acidosis: Low Arterial Blood pH with Increased Arterial pCO2 and Arterial H2CO3- Increased
Neuromuscular disorders that decrease breathing, as produced by brain stem injury, myasthenia gravis, and poliomyelitis
If sufficiently severe, multiple non-neuromuscular causes of impaired ventilation, perfusion, or gas diffusion produced by embolism, infection, selected cancers, asthma, bronchitis, and emphysema.
Suggested Additional Lab Testing
Serial blood gases to assess arterial pH, arterial pco2 and arterial h2co3 are important to determine the severity and progression of disorders producing respiratory acidosis.
Any neuromuscular disorder or non-neuromuscular disorder leading to respiratory acidosis must be specifically identified from clinical signs and symptoms and other diagnostic tests.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Endocrinology Advisor Articles
- Triple-Goal Achievement Reduces Risk for Complications in Type 2 Diabetes
- Inverse Association Between Serum 25(OH)D Levels and Risk for Diabetes
- ADA Issues White Paper Addressing Escalating Cost of Insulin
- Serum Chemerin May Predict Risk for Spontaneous Abortion in Women With PCOS
- Neprilysin Inhibition May Reduce Renal Function Deterioration in Comorbid T2D and Chronic Heart Failure
- Diabetes Treatments
- Incretins, Thiazolidinediones Associated With Better Glycemic Control in T2D
- No Link Between HbA1c Levels and Wound Healing in Patients With Diabetic Foot Ulcers
- Risk for Fetal Loss Early in Pregnancy Not Greater With Noninsulin vs Insulin Therapy
- Use of In-Hospital Continuous Subcutaneous Insulin Infusion: A Consensus Statement
- Effect of Acetyl-L-Carnitine on Blood Pressure in Type 2 Diabetes
- PAH Risk, Mortality Increased by Disturbances in Male Sex Hormones
- Perioperative Cardiovascular Events More Common in Diabetes
- Individuals With Type 1 Diabetes See Improvement With Continuous Glucose Monitoring
- Oral T1D Treatment Zynquista to Be Reviewed by FDA